Sonoma Pharmaceuticals, Inc. (SNOA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.59M |
| Enterprise Value | 2.03M |
| P/E Ratio | -0.61 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0.1 |
| Price/Book Ratio | 0.66 |
| Enterprise/Revenue | 0.02 |
| Enterprise/EBITDA | -0.13 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.16 |
| Operating Margin | -0.13 |
| Return On Assets | -0.23 |
| Return On Equity | -0.88 |
| Revenue | 19.53M |
| Revenue/Share | 11.07 |
| Gross Profit | 7.42M |
| EBITDA | -2.32M |
| Net Income | -3.18M |
| Diluted EPS | -1.89 |
| Total Cash | 2.4M |
| Total Cash/Share | 1.36 |
| Total Debt | 842,000 |
| Total Debt/Equity | 0.27 |
| Current Ratio | 2.5 |
| Book Value Per Share | 1.75 |
| 52-Week Change | -60.54 |
| 52-Week High | 6.92 |
| 52-Week Low | 0.85 |
| Moving Average 50 Days | 1.37 |
| Moving Average 200 Days | 2.9 |
| Average Volume | 225,530 |
| Shares Outstanding | 1.68M |
| % Held by Institutions | 3.94 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | August 30, 2024 |